Literature DB >> 2760987

Hepatitis B virus transcript produced by RNA splicing.

T S Su1, C J Lai, J L Huang, L H Lin, Y K Yauk, C M Chang, S J Lo, S H Han.   

Abstract

A new hepatitis B virus (HBV) transcript of about 2.2 kilobases was identified in HBV DNA-transfected human hepatoma cells. The 5' terminus of this viral RNA appears to map at one or more of the precore initiation sites, contains a deletion of 1,223 bases corresponding to the last codon of the core gene to the middle of the surface antigen gene, and terminates at the 3' polyadenylation site used by the other known HBV RNAs. The junction region of the deleted sequences showed the conserved splice donor and acceptor GT-AG sequences. Moreover, when a mutant HBV DNA in which the splice acceptor site was changed from AG to CG was transfected into human hepatoma cells, no 2.2-kilobase RNA was detected, further suggesting that this RNA represents a spliced transcript. The core gene, although an amino acid shorter, still encoded a functional viral core protein in complementation experiments. Sequence analysis of the cDNA of the 2.2-kilobase RNA suggests that this transcript can potentially encode a new protein that comprises the reverse transcriptase domain of HBV. However, genetic analysis using a transient DNA transfection system suggests that the gene product(s) of this transcript is not essential for viral replication. The function of this transcript remains to be studied.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760987      PMCID: PMC250998          DOI: 10.1128/JVI.63.9.4011-4018.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Analysis of hepatitis B virus transcripts in infected human livers.

Authors:  T S Su; W Y Lui; L H Lin; S H Han; F K P'eng
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

2.  Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteins.

Authors:  H J Schlicht; G Radziwill; H Schaller
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

3.  Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.

Authors:  G M Wahl; R A Padgett; G R Stark
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Dideoxy sequencing method using denatured plasmid templates.

Authors:  M Hattori; Y Sakaki
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

6.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 7.  Persistent infection of humans with hepatitis B virus: mechanisms and consequences.

Authors:  D Ganem
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription.

Authors:  M Büscher; W Reiser; H Will; H Schaller
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

10.  Transcription of woodchuck hepatitis virus in the chronically infected liver.

Authors:  T Möröy; J Etiemble; C Trépo; P Tiollais; M A Buendia
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  39 in total

1.  Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis.

Authors:  T T Wu; L D Condreay; L Coates; C Aldrich; W Mason
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Infection initiated by the RNA pregenome of a DNA virus.

Authors:  M J Huang; J Summers
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted.

Authors:  M Melegari; P P Scaglioni; J R Wands
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 4.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

5.  A Cytoplasmic RNA Virus Alters the Function of the Cell Splicing Protein SRSF2.

Authors:  Efraín E Rivera-Serrano; Ethan J Fritch; Elizabeth H Scholl; Barbara Sherry
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

6.  In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.

Authors:  P Soussan; F Garreau; H Zylberberg; C Ferray; C Brechot; D Kremsdorf
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 7.  Molecular biology of the hepatitis B virus for clinicians.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2012-10-18

8.  Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

Authors:  J E Donello; J E Loeb; T J Hope
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome.

Authors:  T Suzuki; N Masui; K Kajino; I Saito; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 10.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.